Michael S. Rabin

Radiology
17 Ober Rd
Newton, MA 02459

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 33 publications

Exceptional Response to Bromodomain and Extraterminal Domain Inhibitor Therapy With BMS-986158 in BRD4-NUTM1 NUT Carcinoma Harboring a BRD4 Splice Site Mutation.

Exceptional Response to Bromodomain and Extraterminal Domain Inhibitor Therapy With BMS-986158 in BRD4-NUTM1 NUT Carcinoma Harboring a BRD4 Splice Site Mutation.

Journal: JCO precision oncology
Published: June 29, 2023

Pembrolizumab-associated expansion of radiation-induced morphoea responsive to dupilumab: a case report.

Pembrolizumab-associated expansion of radiation-induced morphoea responsive to dupilumab: a case report.

Journal: Clinical and experimental dermatology
Published: November 03, 2022

Osimertinib-Induced Cutaneous Vasculitis Responsive to Low-Dose Dapsone Without Interruption of Anticancer Therapy: A Case Report and Review of the Literature.

Osimertinib-Induced Cutaneous Vasculitis Responsive to Low-Dose Dapsone Without Interruption of Anticancer Therapy: A Case Report and Review of the Literature.

Journal: JTO clinical and research reports
Published: September 12, 2022

Safety of image guided research biopsies in patients with thoracic malignancies.

Safety of image guided research biopsies in patients with thoracic malignancies.

Journal: Lung cancer (Amsterdam, Netherlands)
Published: June 16, 2022

Phase II Study of Lorlatinib in Patients With Anaplastic Lymphoma Kinase-Positive Lung Cancer and CNS-Specific Relapse.

Phase II Study of Lorlatinib in Patients With Anaplastic Lymphoma Kinase-Positive Lung Cancer and CNS-Specific Relapse.

Journal: JCO precision oncology
Published: May 18, 2022

Association between Smoking History and Tumor Mutation Burden in Advanced Non-Small Cell Lung Cancer.

Association between Smoking History and Tumor Mutation Burden in Advanced Non-Small Cell Lung Cancer.

Journal: Cancer research
Published: December 01, 2020

High Sensitivity of Plasma Cell-Free DNA Genotyping in Cases With Evidence of Adequate Tumor Content.

High Sensitivity of Plasma Cell-Free DNA Genotyping in Cases With Evidence of Adequate Tumor Content.

Journal: JCO precision oncology
Published: October 20, 2020

Turnaround Time of Plasma Next-Generation Sequencing in Thoracic Oncology Patients: A Quality Improvement Analysis.

Turnaround Time of Plasma Next-Generation Sequencing in Thoracic Oncology Patients: A Quality Improvement Analysis.

Journal: JCO precision oncology
Published: July 31, 2020

Clinical Decision Support for Symptom Management in Lung Cancer Patients: A Group RCT.

Clinical Decision Support for Symptom Management in Lung Cancer Patients: A Group RCT.

Journal: Journal of pain and symptom management
Published: June 30, 2020

Identification of a RAS-activating TMEM87A-RASGRF1 Fusion in an Exceptional Responder to Sunitinib with Non-Small Cell Lung Cancer.

Identification of a RAS-activating TMEM87A-RASGRF1 Fusion in an Exceptional Responder to Sunitinib with Non-Small Cell Lung Cancer.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: February 03, 2020

Interstitial lung abnormality in stage IV non-small cell lung cancer: A validation study for the association with poor clinical outcome.

Interstitial lung abnormality in stage IV non-small cell lung cancer: A validation study for the association with poor clinical outcome.

Journal: European journal of radiology open
Published: March 08, 2019

Outcomes by EGFR, KRAS, and ALK Genotype After Combined Modality Therapy for Locally Advanced Non-Small-Cell Lung Cancer.

Outcomes by EGFR, KRAS, and ALK Genotype After Combined Modality Therapy for Locally Advanced Non-Small-Cell Lung Cancer.

Journal: JCO precision oncology
Published: November 01, 2018
Showing 1-12 of 33

Last Updated: 09/26/2026